Cedar Brook Financial Partners, LLC Zoetis Inc. Transaction History

Cedar Brook Financial Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$165.67 - $199.94 $9,774 - $11,796	-59 Reduced 3.74%	1,517 $256,000
Q4 2023 Jan 12, 2024	SELL	$151.44 - $200.09 $41,040 - $54,224	-271 Reduced 14.67%	1,576 $311,000
Q3 2023 Oct 17, 2023	SELL	$167.14 - $192.77 $23,065 - $26,602	-138 Reduced 6.95%	1,847 $321,000
Q2 2023 Jul 05, 2023	BUY	$160.94 - $186.23 $319,465 - $369,666	1,985 New	1,985 $341,000
Q2 2022 Aug 12, 2022	SELL	$155.97 - $200.09 $174,530 - $223,900	-1,119 Closed	0 $0
Q1 2022 Apr 06, 2022	BUY	$181.39 - $234.03 $17,050 - $21,998	94 Added 9.17%	1,119 $211,000
Q4 2021 Jan 27, 2022	BUY	$193.69 - $247.03 $198,532 - $253,205	1,025 New	1,025 $250,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.